 |
(3S)-3-[({1-(2-Chlorobenzyl)-4-hydroxy-5-methyl-2-oxo-1,2-dihydropyridin-3yl}amino)carbonyl]amino-3-(4-methylphenyl)propanoic acid monosodium salt |
|---|---|
| Trade Name | |
| Orphan Indication | For mobilization of hematopoietic stem cells |
| USA Market Approval | USA |
| USA Designation Date | 2016-04-25 00:00:00 |
| Sponsor | Aviara Pharmaceuticals, Inc/;3331 Green Tree Park;Houston, Texas, 77027 |
